Article info
PostScript
Letter
Reconsidering the revised amyotrophic lateral sclerosis functional rating scale for ALS clinical trials
- Correspondence to Dr Ruben P A van Eijk, Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands; R.P.A.vanEijk-2{at}umcutrecht.nl
Citation
Reconsidering the revised amyotrophic lateral sclerosis functional rating scale for ALS clinical trials
Publication history
- Received September 27, 2020
- Revised October 28, 2020
- Accepted November 5, 2020
- First published November 23, 2020.
Online issue publication
April 15, 2021
Article Versions
- Previous version (23 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.